These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 736990)

  • 1. Effects of prior administration of methionine sulfoximine on the thresholds of seizures induced in mice by 3-mercaptopropionic acid or pentylenetetrazol.
    Stone WE; Javid MJ
    Biochem Pharmacol; 1978; 27(24):2972-3. PubMed ID: 736990
    [No Abstract]   [Full Text] [Related]  

  • 2. Free amino acids and glutamate decarboxylase activity in brain of mice during drug-induced convulsions.
    Tapia R; Pasantes H; Pérez de la Mora M; Ortega BG; Massieu GH
    Biochem Pharmacol; 1967 Mar; 16(3):483-96. PubMed ID: 6040378
    [No Abstract]   [Full Text] [Related]  

  • 3. Mercaptopropionic acid: a convulsant that inhibits glutamate decarboxylase.
    Lamar C
    J Neurochem; 1970 Feb; 17(2):165-70. PubMed ID: 5494047
    [No Abstract]   [Full Text] [Related]  

  • 4. The convulsant drugs 3-mercaptopropionate and methionine sulfoximine inhibit L-glutamate and L-aspartate binding to a hydrophobic protein fraction from rat cerebral cortex.
    Sábato UC; Fiszer de Plazas S; De Robertis E
    Neurochem Res; 1979 Dec; 4(6):713-22. PubMed ID: 545163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anticonvulsant activity of ketamine agains siezures induced by pentylenetetrazol and mercaptopropionic acid.
    Taberner PV
    Eur J Pharmacol; 1976 Oct; 39(2):305-11. PubMed ID: 976326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between immature and adult rats in brain glutamate decarboxylase inhibition by 3-mercaptopropionic acid.
    Netopilová M; Drsata J; Kubová H; Mares P
    Epilepsy Res; 1995 Mar; 20(3):179-84. PubMed ID: 7796789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconvulsive changes in brain glucose metabolism following drugs inhibiting glutamate decarboxylase.
    Horton RW; Meldrum BS
    J Neurochem; 1976 Apr; 26(4):805-9. PubMed ID: 965969
    [No Abstract]   [Full Text] [Related]  

  • 8. Measuring changes in cerebral glutamate and GABA metabolism prior to convulsions induced by 3-mercaptopropionate.
    Adcock T; Taberner PV
    Biochem Pharmacol; 1978 Jan; 27(2):246-8. PubMed ID: 623679
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscimol and gamma-hydroxybutyrate: similar interactions with convulsant agents.
    Unnerstall JR; Pizzi WJ
    Life Sci; 1981 Jul; 29(4):337-44. PubMed ID: 7278491
    [No Abstract]   [Full Text] [Related]  

  • 10. 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine.
    Löscher W
    Biochem Pharmacol; 1979 Apr; 28(8):1397-407. PubMed ID: 444305
    [No Abstract]   [Full Text] [Related]  

  • 11. Selection of two lines of mice based on latency to onset of methionine sulfoximine seizures.
    Cloix JF; Tahi Z; Martin B; Hévor T
    Epilepsia; 2010 Jan; 51(1):118-28. PubMed ID: 20015245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 3-mercaptopropionate, an inhibitor of glutamate decarboxylase, on the levels of GABA and other amino acids, and on presynaptic inhibition in the rat cuneate nucleus.
    Roberts F; Taberner PV; Hill RG
    Neuropharmacology; 1978 Sep; 17(9):715-20. PubMed ID: 692829
    [No Abstract]   [Full Text] [Related]  

  • 13. Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase.
    Horton RW; Meldrum BS
    Br J Pharmacol; 1973 Sep; 49(1):52-63. PubMed ID: 4207045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of cyclic AMP and phosphorylase a in mouse cerebral cortex during seizures induced by 3-mercaptopropionic acid.
    Folbergrová J
    Brain Res; 1977 Oct; 135(2):337-46. PubMed ID: 200304
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the glutamic acid decarboxylase inhibitor 3-mercaptopropionic acid on the synthesis of brain GABA in vivo and postmortally.
    Lindgren S
    J Neural Transm; 1983; 58(1-2):75-82. PubMed ID: 6655469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic inhibitors and subcellular distribution of GABA.
    Sarhan S; Seiler N
    J Neurosci Res; 1979; 4(5-6):399-421. PubMed ID: 392122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-mercaptopropionic acid: convulsant and lethal properties compared with other sulfur-convulsants; protection therefrom.
    Sprince H; Parker CM; Smith GG
    Agents Actions; 1970 Dec; 1(5):231-3. PubMed ID: 4398717
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticonvulsant characteristics of pyridoxyl-gamma-aminobutyrate, PL-GABA.
    Kang TC; Kang JH; Kim HT; Lee SJ; Choi UK; Kim JE; Kwak SE; Kim DW; Choi SY; Kwon OS
    Neuropharmacology; 2008 May; 54(6):954-64. PubMed ID: 18346762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The susceptibility to audiogenic stimuli of rats treated with methionine sulfoximine and various psychoactive agents.
    Wada JA; Ikeda H; McGeer EG
    Exp Neurol; 1967 Jul; 18(3):327-37. PubMed ID: 5298251
    [No Abstract]   [Full Text] [Related]  

  • 20. Seizure susceptibility in the developing mouse and its relationship to glutamate decarboxylase and pyridoxal phosphate in brain.
    Tapia R; Pasantes-Morales H; Taborda E; Pérez de la Mora M
    J Neurobiol; 1975 Mar; 6(2):159-70. PubMed ID: 171340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.